Mansinho A; Atkinson V; L Bedard P; Gajate P; T Brown J; Cabezón-Gutiérrez L; Duffy A; Moreno V; A Margolin K; Twardowski P; Moreno I; Shue H; Winer I; J Chisamore M; Oliva M; Prawira A; Merchant F; Merchant R; D Gwynne W; D To M; Ibrahim N; Yavari A; Coello M; A Tawbi H; Coelho S; Medic I; Hernandez-Guerrero T; A Ascierto P,
2026,
'517 MDNA11 demonstrates clinical activity as monotherapy and in combination with pembrolizumab in biomarker-enriched gastrointestinal malignancies, including ICI-refractory disease',
BMJ,
pp. a578 - a578, presented at Regular Abstracts,
http://dx.doi.org/10.1136/jitc-2026-sitc2026.0517